Seventh Annual Miami Neuro Symposium Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. * *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree NA=Not applicable to my practice

	5	4	3	2	1	NA
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1	The information and/or skills learned will enhance my professional competence or ability. - NA
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - NA

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	Not Applicable
Apply the 2018 AHA/ASA updated guidelines of acute stroke care.	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - 5	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - 4	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - 3	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - 2	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - 1	Apply the 2018 AHA/ASA updated guidelines of acute stroke care. - Not Applicable
Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke.	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - 5	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - 4	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - 3	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - 2	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - 1	Recognize the value of upcoming clinical trials on non-interventional treatment of acute ischemic stroke. - Not Applicable
Explain the epidemiology and natural course of unruptured cerebral aneurysms.	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - 5	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - 4	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - 3	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - 2	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - 1	Explain the epidemiology and natural course of unruptured cerebral aneurysms. - Not Applicable
Recognize the symptoms associated with unruptured cerebral aneurysms.	Recognize the symptoms associated with unruptured cerebral aneurysms. - 5	Recognize the symptoms associated with unruptured cerebral aneurysms. - 4	Recognize the symptoms associated with unruptured cerebral aneurysms. - 3	Recognize the symptoms associated with unruptured cerebral aneurysms. - 2	Recognize the symptoms associated with unruptured cerebral aneurysms. - 1	Recognize the symptoms associated with unruptured cerebral aneurysms. - Not Applicable
Recognize the importance of developing stroke systems of care.	Recognize the importance of developing stroke systems of care. - 5	Recognize the importance of developing stroke systems of care. - 4	Recognize the importance of developing stroke systems of care. - 3	Recognize the importance of developing stroke systems of care. - 2	Recognize the importance of developing stroke systems of care. - 1	Recognize the importance of developing stroke systems of care. - Not Applicable
Identify patients with posterior circulation stroke.	Identify patients with posterior circulation stroke. - 5	Identify patients with posterior circulation stroke. - 4	Identify patients with posterior circulation stroke. - 3	Identify patients with posterior circulation stroke. - 2	Identify patients with posterior circulation stroke. - 1	Identify patients with posterior circulation stroke. - Not Applicable
Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment.	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - 5	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - 4	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - 3	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - 2	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - 1	Recognize the limitations associated with clinical scale assessments that determine eligibility for acute reperfusion treatment. - Not Applicable
Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor.	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - 5	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - 4	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - 3	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - 2	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - 1	Determine when to triage posterior circulation stroke patients to ICU, neuro-stepdown or floor. - Not Applicable
Select patients for early surgical decompression or medical cytotoxic edema treatment.	Select patients for early surgical decompression or medical cytotoxic edema treatment. - 5	Select patients for early surgical decompression or medical cytotoxic edema treatment. - 4	Select patients for early surgical decompression or medical cytotoxic edema treatment. - 3	Select patients for early surgical decompression or medical cytotoxic edema treatment. - 2	Select patients for early surgical decompression or medical cytotoxic edema treatment. - 1	Select patients for early surgical decompression or medical cytotoxic edema treatment. - Not Applicable
Analyze the importance medical illness plays in the decision-making process.	Analyze the importance medical illness plays in the decision-making process. - 5	Analyze the importance medical illness plays in the decision-making process. - 4	Analyze the importance medical illness plays in the decision-making process. - 3	Analyze the importance medical illness plays in the decision-making process. - 2	Analyze the importance medical illness plays in the decision-making process. - 1	Analyze the importance medical illness plays in the decision-making process. - Not Applicable
Analyze the pros and cons of anticoagulation following ICH or ischemic stroke.	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - 5	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - 4	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - 3	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - 2	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - 1	Analyze the pros and cons of anticoagulation following ICH or ischemic stroke. - Not Applicable
Appropriately select patients who would benefit from early anticoagulation.	Appropriately select patients who would benefit from early anticoagulation. - 5	Appropriately select patients who would benefit from early anticoagulation. - 4	Appropriately select patients who would benefit from early anticoagulation. - 3	Appropriately select patients who would benefit from early anticoagulation. - 2	Appropriately select patients who would benefit from early anticoagulation. - 1	Appropriately select patients who would benefit from early anticoagulation. - Not Applicable
Describe the mechanisms of elevated intracranial pressure.	Describe the mechanisms of elevated intracranial pressure. - 5	Describe the mechanisms of elevated intracranial pressure. - 4	Describe the mechanisms of elevated intracranial pressure. - 3	Describe the mechanisms of elevated intracranial pressure. - 2	Describe the mechanisms of elevated intracranial pressure. - 1	Describe the mechanisms of elevated intracranial pressure. - Not Applicable
Identify those patients at risk of elevated intracranial pressure.	Identify those patients at risk of elevated intracranial pressure. - 5	Identify those patients at risk of elevated intracranial pressure. - 4	Identify those patients at risk of elevated intracranial pressure. - 3	Identify those patients at risk of elevated intracranial pressure. - 2	Identify those patients at risk of elevated intracranial pressure. - 1	Identify those patients at risk of elevated intracranial pressure. - Not Applicable
Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury.	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - 5	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - 4	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - 3	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - 2	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - 1	Effectively treat intracranial pressure and select patients for neurosurgical procedures to prevent herniation and neurologic injury. - Not Applicable
Examine the latest national guidelines on declaration of death by neurologic criteria.	Examine the latest national guidelines on declaration of death by neurologic criteria. - 5	Examine the latest national guidelines on declaration of death by neurologic criteria. - 4	Examine the latest national guidelines on declaration of death by neurologic criteria. - 3	Examine the latest national guidelines on declaration of death by neurologic criteria. - 2	Examine the latest national guidelines on declaration of death by neurologic criteria. - 1	Examine the latest national guidelines on declaration of death by neurologic criteria. - Not Applicable
Examine an evidence-based approach for the clinical management of the comatose patient.	Examine an evidence-based approach for the clinical management of the comatose patient. - 5	Examine an evidence-based approach for the clinical management of the comatose patient. - 4	Examine an evidence-based approach for the clinical management of the comatose patient. - 3	Examine an evidence-based approach for the clinical management of the comatose patient. - 2	Examine an evidence-based approach for the clinical management of the comatose patient. - 1	Examine an evidence-based approach for the clinical management of the comatose patient. - Not Applicable
Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage.	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - 5	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - 4	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - 3	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - 2	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - 1	Recognize the current recommendations in the treatment and management of subarachnoid hemorrhage. - Not Applicable
Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE).	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - 5	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - 4	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - 3	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - 2	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - 1	Examine the updated classifications of seizures and epilepsy recently published by the International League Against Epilepsy (ILAE). - Not Applicable
Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality.	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - 5	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - 4	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - 3	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - 2	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - 1	Recognize that status epilepticus is a medical emergency associated with significant morbidity and mortality. - Not Applicable
Appropriately manage status epilepticus following an established treatment algorithm.	Appropriately manage status epilepticus following an established treatment algorithm. - 5	Appropriately manage status epilepticus following an established treatment algorithm. - 4	Appropriately manage status epilepticus following an established treatment algorithm. - 3	Appropriately manage status epilepticus following an established treatment algorithm. - 2	Appropriately manage status epilepticus following an established treatment algorithm. - 1	Appropriately manage status epilepticus following an established treatment algorithm. - Not Applicable
Review approaches to treatment and counseling of women with epilepsy during child-bearing age.	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - 5	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - 4	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - 3	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - 2	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - 1	Review approaches to treatment and counseling of women with epilepsy during child-bearing age. - Not Applicable
Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series.	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - 5	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - 4	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - 3	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - 2	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - 1	Review indications for and the benefits and risks of surgical interventions for epilepsy based on evidence from randomized controlled trials, cohort studies and case series. - Not Applicable
Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research.	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - 5	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - 4	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - 3	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - 2	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - 1	Examine the associated neuropsychiatric comorbidities of Tourette syndrome with emphasis on recent research. - Not Applicable
Explain recent controversies regarding the etiology of Parkinson’s disease.	Explain recent controversies regarding the etiology of Parkinson’s disease. - 5	Explain recent controversies regarding the etiology of Parkinson’s disease. - 4	Explain recent controversies regarding the etiology of Parkinson’s disease. - 3	Explain recent controversies regarding the etiology of Parkinson’s disease. - 2	Explain recent controversies regarding the etiology of Parkinson’s disease. - 1	Explain recent controversies regarding the etiology of Parkinson’s disease. - Not Applicable
Examine the pathophysiology of functional movement disorders.	Examine the pathophysiology of functional movement disorders. - 5	Examine the pathophysiology of functional movement disorders. - 4	Examine the pathophysiology of functional movement disorders. - 3	Examine the pathophysiology of functional movement disorders. - 2	Examine the pathophysiology of functional movement disorders. - 1	Examine the pathophysiology of functional movement disorders. - Not Applicable

How effective were the following speakers in meeting the learning objectives?

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective, N/A= Not Applicable

Friday *

	5	4	3	2	1	Not Applicable
Guidelines Update - Felipe De Los Rios, M.D.	Guidelines Update - Felipe De Los Rios, M.D. - 5	Guidelines Update - Felipe De Los Rios, M.D. - 4	Guidelines Update - Felipe De Los Rios, M.D. - 3	Guidelines Update - Felipe De Los Rios, M.D. - 2	Guidelines Update - Felipe De Los Rios, M.D. - 1	Guidelines Update - Felipe De Los Rios, M.D. - Not Applicable
Advanced Imaging - Kevin Abrams, M.D.	Advanced Imaging - Kevin Abrams, M.D. - 5	Advanced Imaging - Kevin Abrams, M.D. - 4	Advanced Imaging - Kevin Abrams, M.D. - 3	Advanced Imaging - Kevin Abrams, M.D. - 2	Advanced Imaging - Kevin Abrams, M.D. - 1	Advanced Imaging - Kevin Abrams, M.D. - Not Applicable
New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D.	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - 5	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - 4	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - 3	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - 2	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - 1	New Approach to Ruptured Cerebral Aneurysms - Italo Linfante, M.D. - Not Applicable
Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D.	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - 5	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - 4	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - 3	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - 2	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - 1	Current and Future Treatment of Unruptured Cerebral Aneurysms - Guilherme Dabus, M.D. - Not Applicable
Stroke Systems of Care - Brett Kissela, M.D.	Stroke Systems of Care - Brett Kissela, M.D. - 5	Stroke Systems of Care - Brett Kissela, M.D. - 4	Stroke Systems of Care - Brett Kissela, M.D. - 3	Stroke Systems of Care - Brett Kissela, M.D. - 2	Stroke Systems of Care - Brett Kissela, M.D. - 1	Stroke Systems of Care - Brett Kissela, M.D. - Not Applicable
Posterior Circulation Stroke - Brett Kissela, M.D.	Posterior Circulation Stroke - Brett Kissela, M.D. - 5	Posterior Circulation Stroke - Brett Kissela, M.D. - 4	Posterior Circulation Stroke - Brett Kissela, M.D. - 3	Posterior Circulation Stroke - Brett Kissela, M.D. - 2	Posterior Circulation Stroke - Brett Kissela, M.D. - 1	Posterior Circulation Stroke - Brett Kissela, M.D. - Not Applicable
Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D.	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - 5	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - 4	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - 3	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - 2	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - 1	Struck Down: How Strokes in Six World Leaders Impacted the History of the 20th Century - Michael DeGeorgia, M.D. - Not Applicable
Anticoagulation after ICH and Stroke - Kiwon Lee, M.D.	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - 5	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - 4	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - 3	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - 2	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - 1	Anticoagulation after ICH and Stroke - Kiwon Lee, M.D. - Not Applicable
Management of ICP - Mohamed Abou El Fadi, M.D.	Management of ICP - Mohamed Abou El Fadi, M.D. - 5	Management of ICP - Mohamed Abou El Fadi, M.D. - 4	Management of ICP - Mohamed Abou El Fadi, M.D. - 3	Management of ICP - Mohamed Abou El Fadi, M.D. - 2	Management of ICP - Mohamed Abou El Fadi, M.D. - 1	Management of ICP - Mohamed Abou El Fadi, M.D. - Not Applicable
Diagnosis of Brain Death - Kiwon Lee, M.D.	Diagnosis of Brain Death - Kiwon Lee, M.D. - 5	Diagnosis of Brain Death - Kiwon Lee, M.D. - 4	Diagnosis of Brain Death - Kiwon Lee, M.D. - 3	Diagnosis of Brain Death - Kiwon Lee, M.D. - 2	Diagnosis of Brain Death - Kiwon Lee, M.D. - 1	Diagnosis of Brain Death - Kiwon Lee, M.D. - Not Applicable
Approach to the Comatose Patient - Karel Fuentes, M.D.	Approach to the Comatose Patient - Karel Fuentes, M.D. - 5	Approach to the Comatose Patient - Karel Fuentes, M.D. - 4	Approach to the Comatose Patient - Karel Fuentes, M.D. - 3	Approach to the Comatose Patient - Karel Fuentes, M.D. - 2	Approach to the Comatose Patient - Karel Fuentes, M.D. - 1	Approach to the Comatose Patient - Karel Fuentes, M.D. - Not Applicable
Management of SAH - Edwin Wu, M.D.	Management of SAH - Edwin Wu, M.D. - 5	Management of SAH - Edwin Wu, M.D. - 4	Management of SAH - Edwin Wu, M.D. - 3	Management of SAH - Edwin Wu, M.D. - 2	Management of SAH - Edwin Wu, M.D. - 1	Management of SAH - Edwin Wu, M.D. - Not Applicable

Saturday *

	5	4	3	2	1	Not Applicable
Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D.	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - 5	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - 4	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - 3	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - 2	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - 1	Seizure Classification and Update in Seizure Medication - Selim Benbadis, M.D. - Not Applicable
Status Epilepticus - Alberto Pinzon-Ardila, M.D.	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - 5	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - 4	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - 3	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - 2	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - 1	Status Epilepticus - Alberto Pinzon-Ardila, M.D. - Not Applicable
Epilepsy in Women - Selim Benbadis, M.D.	Epilepsy in Women - Selim Benbadis, M.D. - 5	Epilepsy in Women - Selim Benbadis, M.D. - 4	Epilepsy in Women - Selim Benbadis, M.D. - 3	Epilepsy in Women - Selim Benbadis, M.D. - 2	Epilepsy in Women - Selim Benbadis, M.D. - 1	Epilepsy in Women - Selim Benbadis, M.D. - Not Applicable
Surgical Management of Epilepsy - Vitaly Siomin, M.D.	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - 5	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - 4	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - 3	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - 2	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - 1	Surgical Management of Epilepsy - Vitaly Siomin, M.D. - Not Applicable
Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D.	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - 5	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - 4	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - 3	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - 2	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - 1	Tourette Syndrome and Related Co-morbidities: Treatment Optimization - Jorge L. Juncos, M.D. - Not Applicable
Advancement in Parkinson Disease - Bruno Gallo, M.D.	Advancement in Parkinson Disease - Bruno Gallo, M.D. - 5	Advancement in Parkinson Disease - Bruno Gallo, M.D. - 4	Advancement in Parkinson Disease - Bruno Gallo, M.D. - 3	Advancement in Parkinson Disease - Bruno Gallo, M.D. - 2	Advancement in Parkinson Disease - Bruno Gallo, M.D. - 1	Advancement in Parkinson Disease - Bruno Gallo, M.D. - Not Applicable
Functional Movement Disorders - Jorge L. Juncos, M.D.	Functional Movement Disorders - Jorge L. Juncos, M.D. - 5	Functional Movement Disorders - Jorge L. Juncos, M.D. - 4	Functional Movement Disorders - Jorge L. Juncos, M.D. - 3	Functional Movement Disorders - Jorge L. Juncos, M.D. - 2	Functional Movement Disorders - Jorge L. Juncos, M.D. - 1	Functional Movement Disorders - Jorge L. Juncos, M.D. - Not Applicable

Was this course fair, balanced and without commercial bias? *

Yes

No

Participation in this learning activity has: *

	Yes	No	Not Applicable
Increased my knowledge	Increased my knowledge - Yes	Increased my knowledge - No	Increased my knowledge - Not Applicable
Enhanced my performance	Enhanced my performance - Yes	Enhanced my performance - No	Enhanced my performance - Not Applicable
Improved my competence	Improved my competence - Yes	Improved my competence - No	Improved my competence - Not Applicable
Ensured that my patients will have improved outcomes	Ensured that my patients will have improved outcomes - Yes	Ensured that my patients will have improved outcomes - No	Ensured that my patients will have improved outcomes - Not Applicable

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

Seventh Annual Miami Neuro Symposium Evaluation